Rani Therapeutics LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Rani Therapeutics LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH495194D
  • |
  • Pages: 24
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Rani Therapeutics LLC (Rani Therapeutics) is a biopharmaceutical company that develops drug molecules. The company provides oral delivery of drug molecules such as peptides, proteins and antibodies. It offers biologics in the form of an oral pill as a replacement to biologics injections. Rani Therapeutics' product portfolio includes TNFa inhibitors, parathyroid hormone, human growth hormone, somatostatin, human interferon beta-1a, GLP-1 analog, basal insulin + GLP-1 analog combination, and Interleukin-17. The company carries out clinical trials on oral forms of Adalimumab and human insulin. It conducts research to develop its approach and technology at InCube Labs, a multi-disciplinary life sciences laboratory that develops medical innovations. Rani Therapeutics is headquartered in San Jose, California, the US.

Rani Therapeutics LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Rani Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Rani Therapeutics LLC, Medical Devices Deals, 2011 to YTD 2017 9

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Rani Therapeutics Raises Funds in Financing 11

Rani Therapeutics Raises USD25 Million in Series C Venture Financing 12

Rani Therapeutics Raises Funds Through Series B Financing 13

Partnerships 14

Rani Therapeutics Enters into Agreement with MedImmune 14

Rani Therapeutics Enters into Agreement with Novartis 14

Acquisition 15

KPC Pharma to Acquire Stake in Rani Therapeutics for USD5 Million 15

Rani Therapeutics LLC-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Corporate Communications 20

Dec 05, 2016: Rani Therapeutics appoints new board member 20

Dec 05, 2016: Maulik Nanavaty Joins Rani Therapeutics Board 21

Oct 11, 2016: David Pyott Joins Rani Therapeutics Board 22

Other Significant Developments 23

Feb 24, 2016: Rani Therapeutics Completes Latest Round of Funding; Brings Total Investment to $70M 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24

List of Figures

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Rani Therapeutics LLC, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 1

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Rani Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Rani Therapeutics LLC, Deals By Therapy Area, 2011 to YTD 2017 8

Rani Therapeutics LLC, Medical Devices Deals, 2011 to YTD 2017 9

Rani Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Rani Therapeutics Raises Funds in Financing 11

Rani Therapeutics Raises USD25 Million in Series C Venture Financing 12

Rani Therapeutics Raises Funds Through Series B Financing 13

Rani Therapeutics Enters into Agreement with MedImmune 14

Rani Therapeutics Enters into Agreement with Novartis 14

KPC Pharma to Acquire Stake in Rani Therapeutics for USD5 Million 15

Rani Therapeutics LLC, Key Competitors 17

Rani Therapeutics LLC, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Rani Therapeutics LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 18130
Site License
USD 500 INR 36260
Corporate User License
USD 750 INR 54390

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com